Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous HSC Infusion for Post-CAR-T Cytopenia
NCT07127289Phase 2Recruiting
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Aug 2025
- Primary completion
- Aug 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous hematopoietic stem cells in cytopenia, sponsored by Institute of Hematology and Blood Diseases Hospital. Started Aug 2025; status: recruiting.
02
Drugs
autologous hematopoietic stem cells
03
Conditions
cytopenia
Beyond the preview
Go deeper on NCT07127289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07127289.